Classification and structure
Three main chemical classes of calcium channel blockers are used to treat angina pectoris:
- Phenylalkylamines (representative — verapamil).
- Dihydropyridines (nifedipine, amlodipine, etc.).
- Benzothiazepines (diltiazem).
Medicinal agents selectively block L-type voltage-gated calcium channels, which are activated in response to cell membrane depolarization. The main target for the drugs is the α₁-subunit of the channel, which acts as a voltage-sensing sensor. These channels are localized in cardiomyocytes and angiomyocytes — the smooth muscle cells of resistance vessels.
Organ selectivity of drugs
Different groups of CCBs have varying tropism for the tissues of the heart and vascular bed:
- Phenylalkylamines exhibit pronounced cardioselectivity, acting primarily on heart tissue.
- Dihydropyridines have high vasoselectivity and affect blood vessels mainly.
- Benzothiazepines occupy an intermediate position, affecting both the myocardium and the vascular system.
These differences determine the specific pharmacological response and hemodynamic profile of each individual class.
Dihydropyridine derivatives in hypertension
Selective class II calcium channel blockers are widely used as antihypertensive agents. These include dihydropyridine derivatives such as nifedipine, amlodipine, felodipine, nitrendipine, isradipine, and lacidipine.
Calcium ions are critical for maintaining normal vascular tone. Upon depolarization of the angiomyocyte membrane, L-type calcium channels open, allowing calcium ions to enter the cell and increasing their cytoplasmic concentration, which triggers muscle contraction.
By blocking these channels, dihydropyridines disrupt calcium influx, reduce vascular tone, decrease total peripheral resistance (SVR), and lower blood pressure.
Clinical priorities of therapy
The overall pharmacological profile of the group is characterized by a mixed antianginal effect. The drugs simultaneously reduce overall myocardial oxygen demand and increase its delivery to tissues.
When prescribing dihydropyridines in clinical practice, strict priority is given to extended-release drugs. It is precisely these dosage forms that guarantee a stable antihypertensive effect and help minimize adverse hemodynamic side effects.
Briefly: answers to topical questions
What are the main side effects characteristic of short-acting dihydropyridines?
Nifedipine is characterized by the following side effects:
- hypotension — excessive drop in blood pressure;
- reflex tachycardia — a response to vasodilation;
- ankle edema.
Preference is given to extended-release drugs because they provide a stable antihypertensive effect and cause fewer hemodynamic side effects.
Class and exam questions
Which structure of the calcium channel serves as the target for drugs?
The main target for calcium channel blockers is the channel's α₁-subunit, which functions as a voltage-sensitive sensor.
What is the difference in organ selectivity between phenylalkylamines and dihydropyridines?
Phenylalkylamines exhibit cardioselectivity and act primarily on the heart, whereas dihydropyridines possess vasoselectivity and affect vascular smooth muscle mainly.
Which dihydropyridine drugs are preferred in clinical practice?
In clinical practice, priority is given to extended-release medications because they provide a more stable antihypertensive effect and reduce the incidence of side effects.
What else to study on this topic
- Structure of the L-type calcium channel and functions of its subunits
- Mechanisms of negative inotropic effect formation
- Balance of myocardial oxygen supply and demand
- Comparison of pharmacokinetics between short-acting and extended-release dihydropyridines
- The role of benzothiazepines in hemodynamic regulation
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Calcium channel blockers» and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.